Andrew K Godwin Selected Research

Andrew K Godwin Research Topics

Disease

140	Neoplasms (Cancer) 08/2022 - 05/2002
64	Breast Neoplasms (Breast Cancer) 11/2022 - 02/2003
50	Ovarian Neoplasms (Ovarian Cancer) 02/2021 - 01/2002
22	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2018 - 08/2003
19	Carcinoma (Carcinomatosis) 12/2020 - 10/2002
16	Carcinogenesis 01/2018 - 08/2003
14	Ovarian Epithelial Carcinoma 04/2020 - 04/2007
9	Neoplasm Metastasis (Metastasis) 12/2020 - 10/2002
8	Triple Negative Breast Neoplasms 07/2022 - 02/2017
7	Endometrial Neoplasms (Endometrial Cancer) 11/2014 - 06/2009
5	Ewing Sarcoma (Sarcoma, Ewing) 08/2020 - 01/2017
5	Aneuploidy (Aneuploid) 08/2011 - 07/2007
4	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 11/2007
4	Pathologic Complete Response 07/2022 - 02/2017
4	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 09/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 01/2003
4	Renal Cell Carcinoma (Grawitz Tumor) 10/2020 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 11/2018 - 08/2007
3	Ductal Carcinoma 01/2017 - 02/2012
3	Leukemia 01/2017 - 05/2002
3	Disease Progression 12/2012 - 02/2008
3	Lung Neoplasms (Lung Cancer) 04/2011 - 05/2002
2	Residual Neoplasm 01/2022 - 01/2020
2	Infections 01/2022 - 11/2021
2	Genomic Instability 01/2021 - 08/2011
2	Ascites 04/2020 - 01/2007
2	Chromosomal Instability (Chromosome Stability) 08/2017 - 01/2014
2	Tuberous Sclerosis (Bourneville's Disease) 03/2017 - 12/2004

Drug/Important Bio-Agent (IBA)

38	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
30	Estrogen ReceptorsIBA 11/2022 - 03/2006
25	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2007
16	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2003
15	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 08/2003
14	Progesterone Receptors (Progesterone Receptor)IBA 07/2022 - 01/2007
12	Pharmaceutical PreparationsIBA 03/2018 - 09/2002
11	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2007
10	Transcription Factors (Transcription Factor)IBA 08/2022 - 06/2009
10	Biological ProductsIBA 11/2021 - 02/2006
9	Messenger RNA (mRNA)IBA 01/2022 - 05/2002
9	RNA (Ribonucleic Acid)IBA 01/2020 - 02/2008
9	Small Interfering RNA (siRNA)IBA 12/2015 - 04/2005
8	Hormones (Hormone)IBA 01/2022 - 01/2006
8	ErbB Receptors (EGF Receptor)IBA 12/2020 - 08/2002
6	Formaldehyde (Formol)FDA Link 01/2022 - 03/2014
6	PlatinumIBA 12/2018 - 05/2008
6	Insulin-Like PeptidesIBA 01/2013 - 06/2008
5	Estrogens (Estrogen)FDA Link 07/2022 - 01/2011
5	ParaffinIBA 01/2022 - 02/2012
5	taxaneIBA 01/2021 - 05/2008
5	Phosphotransferases (Kinase)IBA 03/2016 - 08/2002
5	Epidermal Growth Factor (EGF)IBA 09/2015 - 08/2002
4	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 11/2014
4	AnthracyclinesIBA 01/2021 - 02/2017
3	NucleotidesIBA 11/2022 - 01/2014
3	ProteomeIBA 01/2022 - 02/2005
3	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 10/2011
3	CytokinesIBA 02/2021 - 06/2009
3	olaparibIBA 01/2021 - 01/2019
3	SteroidsIBA 10/2020 - 01/2006
3	Phenobarbital (Luminal)FDA Link 01/2020 - 06/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2018 - 07/2013
3	CollagenIBA 12/2017 - 05/2002
3	Aurora Kinase AIBA 08/2017 - 07/2007
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017 - 11/2006
3	EnzymesIBA 11/2015 - 01/2007
3	Dasatinib (BMS 354825)FDA Link 01/2015 - 03/2010
3	LigandsIBA 02/2014 - 08/2007
3	Matrix Metalloproteinases (MMPs)IBA 01/2014 - 02/2007
3	Gefitinib (Iressa)FDA Link 06/2013 - 08/2005
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2013 - 06/2009
3	Peptide Hydrolases (Proteases)FDA Link 04/2011 - 02/2004
3	Platelet-Derived Growth Factor alpha ReceptorIBA 10/2008 - 05/2005
2	Conditioned Culture MediaIBA 02/2021 - 01/2007
2	Mitogen-Activated Protein KinasesIBA 02/2021 - 06/2009
2	entinostat (MS 275)IBA 01/2021 - 01/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 04/2020
2	Progesterone FDA LinkGeneric 12/2020 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 12/2020 - 11/2012
2	human ERBB2 proteinIBA 01/2020 - 01/2017
2	ChromatinIBA 01/2020 - 07/2009
2	AntigensIBA 01/2020 - 01/2011
2	IntegrinsIBA 01/2020 - 02/2014
2	Nucleic AcidsIBA 12/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 03/2011
2	EWS-FLI fusion proteinIBA 01/2019 - 12/2018
2	Docetaxel (Taxotere)FDA Link 12/2018 - 02/2017
2	Ligases (Synthetase)IBA 11/2018 - 12/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 01/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 06/2011
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2017 - 01/2014
2	trans-sodium crocetinate (crocetin)IBA 03/2017 - 12/2004
2	Thioredoxin-Disulfide ReductaseIBA 01/2017 - 07/2013
2	Auranofin (Ridaura)FDA Link 01/2017 - 07/2013
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017 - 11/2015
2	ProgranulinsIBA 08/2016 - 02/2012

Therapy/Procedure

34	Therapeutics 07/2022 - 11/2005
13	Drug Therapy (Chemotherapy) 07/2022 - 09/2002
4	Neoadjuvant Therapy 07/2022 - 12/2018
4	Ovariectomy (Oophorectomy) 07/2008 - 12/2003
2	Chemoprevention 12/2017 - 01/2010